Member Info for Gman93

RBO - Scot views these MCAPs as purely ‘oil in the ground’ as I am honestly so sick of hearing. There’s so many other variables that go into this. Has PANRs debt been calculated into this simplistic view of the two companies? Could 88E benefit from being downdip due to the natural formations of gas an oil? Could this also disadvantage them as you suggest? My point being it isn’t this simplistic.

I have no problem nor difficulty understanding of why you would view 88E negatively as a LTH. I also have felt my fair share of issues. What I don’t understand is why you have to combat any positive post with this pessimism? You are welcome to your views of course, like every other poster - but you insist on correcting people as if they are naive for investing here. Of course this could not work out, but what in life is guaranteed other than death (and taxes).

It’s costing £11M just to flow test these 2. Should the company of been diluted more to test these plays? I strongly feel they believe these findings will be sufficient should it flow.

In terms of diversifying, it’s better to have more prospects than all your eggs pretty much in one basket. Should this go to plan and the company financially benefit from the findings/farm out/production/sale, they can then continue to explore and repeat what they have done here.

I appreciate the situation hasn’t been ideal, but what would you have done differently given the opportunity?

RBO - I just don’t understand. You claim your invested yet, you put a pessimistic spin on anything that is potentially positive. Even if these are your thoughts, why are you so keen to deramp this share if you are invested? Continually raking up negatives. If this flows it is positive for the company and there isn’t a chance this is factored in, especially with previous dusters as you so point out.

IMO, you’re invested in PANR hence the positive spin on the fact they are involved. Let’s be honest, if this flows for 88E, it’s very beneficial for PANR. Boosting their share price due to the development potential on both sides as well as putting pressure on the mangrove short. You constantly support and back Scot who we know is a PANR advocate.

If you’re going to invest in something, at least support it when it’s at that potential turning point. If you think it’s destined to fail and won’t go any higher, sell your shares now and take your own advice. Then please stop commenting on this board.

If anyone disbelieves my opinions, check his posts. Only ever 88E with negative comments. This is not a genuine account and is strongly affiliated with Scot.

Here we go after a long wait since Merlin. Good luck to all those involved. Company is well positioned with TAPS proximity, data available and approach this time around

Anyone know why there’s a notification on the ‘PANR short positions’?

Brom appears when necessary. Lots of hot air at the moment, especially from this Khan fool.

Results will speak for themselves when the time comes. PANR news is promising as they could link with 88E if they also discover lots of gas. With the downdip scenario however don’t think this will be much relatively.

RNS not released but don’t think this will be the catalyst. 88E has an amazing way of creating a spike - I wouldn’t rule it out even if it’s not started to incline the way it typically has. If the first flow test is good, I expect to see a huge spike going into the second.

Only time will tell. Market is wise to previous hype but this time success is much more likely than the previous wildcat drills.

Volume higher than same time yesterday. Good to see this growing.

£850K now time of writing. It’s really beginning.

Volume nearly £700K already. Interesting days ahead

I feel the lack of news here is a bit disappointing. Anticipating CE approval was Q4 23 and here we are half way through Q1 24 without an update. I hope it’s not far away.

Well done Scot, you’ve reeled me in.

Placing at a much higher SP would not be as impactful as if it was right now. Results of the flow test could easily multiply the value of this company.

The herd hasn’t been here since Q2 22’ because that was the last time 88E did a flow test. We all know positive results of the upcoming tests have the potential to significantly change the value of this company. Hence the anticipation of the herd once more.

Again, despite all your detailed analysis, you simplify these 2 companies to just ‘barrels of oil in the ground’, which we know isn’t the actual reflection of the SP. PANR have debt to deal with whereas 88E don’t.

To those who are here often, it’s quite clear you de ramp this share in every way possible to convert them to PANR. You claim to try to ‘warn newcomers’ but as MANY have pointed out, you guided those that listened to you to invest in a company at 130p that dropped to just 10p.

I have respect for your ability to dissect the fundamentals of these companies, but your agenda is very transparent.

GLA and I think it’s a very positive sign when you have someone like this trying to convince the masses otherwise. I don’t think it’s genuine concern for new investors :)

Finally it’s escaped the range of 0.23-0.25. I think this will give those on the sidelines the confidence this is potentially starting. GLA

What a strange week. Was really expecting some big news. Looking more like a P&D at this point.

I’ve also read this to be potentially split amongst a few providers. Great work Nil finding the information.

Looking at trades, lots of small ones and no stand out big ones. Crazy for such an increase on no news and as mentioned, typically quiet period. Next open will be interesting.

Hoping this isn’t a pump and dump.

Even at these prices, the company is still undervalued. Some people must know about CE approval. Don’t think it will be anything but.

Expect to see the RNS first week of Jan IMO. Very bright future here and I have next to no complaints about the way they do business.

We will see shortly if burgundy pay the other half. Can’t see them not doing after committing the first instalment.

I don’t think there is long until we all of a sudden see a big tick up for this share.

Correction - chill has pretty much quadrupled revenue in the second half of the year whilst reducing operating costs.

I believe KNB is on chills website if I am not wrong.

Crazy increase for one day. Lot of us might of got it right saying that was the bottom.

Chill is also up significantly today. Maybe to do with the cannabis sector in general. Definitely an improvement on volume from recent months.

Hopefully this continues tomorrow too. I’m expecting a big year in 24. So many positive RNS since IPO and CE mark will be a big step forward.

GP service and treat it both good revenue streams too. Excited to see what Ian is going to do for the business. GLA. Really feel this will rocket when the time is right.

Good move to save half a mil. Do agree with the previous post that it would be good to see directors getting involved. 88E have a poor reputation at the moment so every move is perceived negatively by many.

Looking forward to the build up to flow tests and beyond. GLA!

Hi RedIrons,

Firstly - thanks for your answer to my question last night.

I’m still unsure however. If the market cap remains the same, then dilution would still occur at the same rate. It’s still just a % discount of the current SP, whether that’s a £0.01 or £1.00.

Is the argument because the dilution in the future doesn’t look as obscene?

Essentially, whether it’s a 100,000 shares or 1,000,000,000,000. You still own the same % of the company for the value you pay. Isn’t it all just pro rata?

From what I’ve read, I haven’t seen one concrete point that actually means this will hurt long term holders. But then at the same time, why would this even be a thing if it’s essentially the same. I guess the figures are just more digestible?

A lot of investors moan about shares in issue and how the company appears unattractive. Surely this can only be beneficial as it doesn’t change value of shares for existing holders. 10 x £20 notes to 4 x £50 notes example.

The summary of operations is much more promising than previous years. Good flow tests should only enable this company to press on with their other operations. I think it’s really positive to see diversity in the portfolio.

Multiple interest from JV partners also appears very promising in relation to Leonis. Look forward to others thoughts on the announcement other than what 88E have done in the past.